MARIE FOBBEN: Open Payments
NPI 1356014518 · FLORHAM PARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,214 in 77 payments from 19 companies in 2025. Trend: 2023 $1,256 · 2024 $1,772 · 2025 $1,214
Food & beverage: $1,214
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $256 |
| Regeneron Healthcare Solutions, Inc. | 6 | $183 |
| Galderma Laboratories, L.P. | 16 | $177 |
| PFIZER INC. | 5 | $92 |
| Lilly USA, LLC | 4 | $76 |
| UCB, Inc. | 4 | $74 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $54 |
| Janssen Biotech, Inc. | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Botanix SB Inc | 2 | $37 |
Products named: SKYRIZI, DUPIXENT, AKLIEF, CIBINQO, RINVOQ, EBGLYSS, Bimzelx, NEMLUVIO.
Industry payments across NJ — which companies pay providers there.
